BCR and B-cell chronic lymphocytic leukemia: Here, we experimentally investigated the presence of AID-dependent mutations accumulated during treatment in a cohort of patients with CLL, and then, using an in vitro model, we evaluated the possible role of AID in the development of resistance to BCR pathway inhibitors in CLL.